Pettorruso, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 1.088
EU - Europa 968
AS - Asia 849
SA - Sud America 180
AF - Africa 25
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.122
Nazione #
US - Stati Uniti d'America 1.056
SG - Singapore 416
DE - Germania 359
CN - Cina 212
BR - Brasile 153
IT - Italia 138
SE - Svezia 131
FR - Francia 85
GB - Regno Unito 75
VN - Vietnam 54
UA - Ucraina 53
IN - India 43
IE - Irlanda 38
ID - Indonesia 24
FI - Finlandia 20
JP - Giappone 16
CA - Canada 15
RU - Federazione Russa 14
NL - Olanda 13
AR - Argentina 12
HK - Hong Kong 12
AT - Austria 10
AU - Australia 10
BD - Bangladesh 9
KR - Corea 9
MX - Messico 9
TR - Turchia 9
IR - Iran 8
PL - Polonia 8
ES - Italia 7
ZA - Sudafrica 7
KE - Kenya 6
MA - Marocco 6
IQ - Iraq 5
PK - Pakistan 5
BE - Belgio 4
EG - Egitto 4
OM - Oman 4
UZ - Uzbekistan 4
CL - Cile 3
EC - Ecuador 3
UY - Uruguay 3
VE - Venezuela 3
AZ - Azerbaigian 2
BZ - Belize 2
HU - Ungheria 2
KZ - Kazakistan 2
LT - Lituania 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CI - Costa d'Avorio 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GL - Groenlandia 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MC - Monaco 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
SA - Arabia Saudita 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.122
Città #
Chandler 213
Singapore 188
Ashburn 84
New York 41
Beijing 37
San Mateo 37
Dublin 36
Rome 34
Los Angeles 33
Jacksonville 32
Hefei 31
Wilmington 30
Munich 28
The Dalles 27
Milan 26
Jakarta 24
Dallas 21
Marseille 20
Boston 19
Dearborn 18
Nanjing 18
Hanoi 17
Nürnberg 15
Ho Chi Minh City 14
Buffalo 12
Falls Church 12
Houston 12
Lawrence 12
Moscow 12
São Paulo 12
Woodbridge 12
Ann Arbor 11
Frankfurt am Main 11
Seattle 11
Tokyo 11
Falkenstein 10
Hong Kong 10
Fairfield 9
Lancaster 9
Poitiers 9
Princeton 9
Redwood City 9
Seoul 9
Boardman 8
Cattolica 7
Kent 7
London 7
Bremen 6
Chennai 6
Guangzhou 6
Montreal 6
Nanchang 6
Norwalk 6
Vienna 6
Brisbane 5
Changsha 5
Columbus 5
Kish 5
Mexico City 5
Mountain View 5
Newark 5
Nuremberg 5
Poplar 5
San Diego 5
Stockholm 5
Swansea 5
Toronto 5
Amsterdam 4
Augusta 4
Bexley 4
Brooklyn 4
Cape Town 4
Chelmsford 4
Chicago 4
Jiaxing 4
Montes Claros 4
Orem 4
Pune 4
Rio de Janeiro 4
Roubaix 4
Tredegar 4
Turku 4
Warsaw 4
Wroclaw 4
Atlanta 3
Baghdad 3
Bauru 3
Bengaluru 3
Cairo 3
Cardiff 3
Córdoba 3
Denver 3
Goiânia 3
Haiphong 3
Lauterbourg 3
Montevideo 3
Muscat 3
Osaka 3
Paris 3
Quito 3
Totale 1.497
Nome #
Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment 305
Dopamine transporter availability in gambling disorder: preliminary 123I-FP-CIT SPECT results 187
PUNDING IN PARKINSON'S DISEASE: THE IMPACT OF PATIANT'S AWARENESS ON DIAGNOSIS 161
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 138
Allostasis as a conceptual framework linking bipolar disorder and addiction 130
Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives 125
Neural correlates of cognitive control in gambling disorder: a systematic review of fMRI studies 119
Amantadine in the treatment of pathological gambling: a case report 118
Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms 113
MANAGEMENT OF PUNDING IN PARKINSON'S DISEASE: AN OPEN-LABEL PROSPECTIVE STUDY 111
Dopaminergic and clinical correlates of high-frequency repetitive transcranial magnetic stimulation in gambling addiction: a SPECT case study. 111
Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity 110
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123 I-FP-CIT SPECT study. 109
Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis 109
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123I-FP-CIT SPECT study 104
Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead 103
Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study 97
Management of aripiprazole-induced tardive Pisa syndrome: A case report and literature review 95
Gender-related psychopathology in opioid use disorder: Results from a representative sample of Italian addiction services 91
Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study. 86
Repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex may improve symptoms of anhedonia in individuals with cocaine use disorder: A pilot study. 83
Dopaminergic dysfunction in the left putamen of patients with major depressive disorder 67
Hopelessness, Dissociative Symptoms, and Suicide Risk in Major Depressive Disorder: Clinical and Biological Correlates 67
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING) 64
Exploring peripheral biomarkers in psychostimulant use: A systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors 57
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 52
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 51
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 47
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study) 44
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 42
Resilience and childhood trauma in mood disorders: Psychopathological implications and treatment response 14
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation 13
Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study 13
Profiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdown 12
Esketamine Treatment Trajectory of Patients with Treatment-Resistant Depression in the Mid and Long-Term Run: Data from REAL-ESK Study Group 12
Evaluating Craving in Alcohol Use Disorder: Psychometric Characteristics of the Craving Typology Questionnaire-15 (CTQ-15) 10
Italian REMS, limits and critical issues: From a clinical case to the comparison with the European forensic systems 2
Totale 3.172
Categoria #
all - tutte 12.774
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.774


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202189 0 0 0 0 0 5 16 3 18 16 26 5
2021/2022227 18 10 3 3 15 11 12 42 11 17 35 50
2022/2023538 61 72 45 99 18 69 23 56 67 6 11 11
2023/2024210 17 68 3 4 8 52 8 0 1 7 20 22
2024/2025586 4 23 32 17 47 10 43 26 93 46 133 112
2025/2026842 213 56 85 145 274 69 0 0 0 0 0 0
Totale 3.172